CTIS.eu › Cities › France › Lille
Lille
France
703 total trials
324 recruiting
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
2024-520045-23-00
4
Kidney cancer
2024-520089-70-00
5
Cutaneous lupus erythematosus
2024-520140-42-00
5
Patients with primary HPV high-grade squamous intra-epithelial lesions
2025-520573-39-00
6
Ultra High Risk of psychosis and first episode psychosis
2025-521113-13-00
10
Early Parkinson’s Disease
2025-521322-14-00
4
Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation,
2025-521493-33-00
5
bronchiectasis unrelated to cystic fibrosis
2025-521619-37-00
5
Patients ≥75 years old with cT3/T4 rectal adenocarcinoma eligible to r
2025-521769-29-00
5
Pulmonary Hypertension Associated with Interstitial Lung Disease
2025-521891-78-00
5
Adult patients with stage IV non squamous non-small cell lung cancer (
2025-522060-32-00
4
STEMI (ST elevated Myocardial Infarction)
2025-522294-11-00
4
Systemic sclerosis
2025-522563-15-00
10
Metastatic Pancreatic Ductal Adenocarcinoma; PDAC
2025-522595-87-00
7
Hematological Malignancies
2025-522790-10-00
4
Non Small Cell Lung Cancer
2025-522801-39-00
4
Stage III Non Small Cell Lung Cancer
2025-522818-23-00
5
Small Cell Lung Cancer (SCLC)
2025-522855-25-00
5
Urinary Bladder Neoplasms
2025-522965-31-00
4
Atopic Dermatitis
2025-523276-23-00
7
Extensive stage small cell lung cancer
2025-523399-22-00
7
Advanced Solid Tumours
2025-523400-72-00
4
Cystic fibrosis
Showing 25–48 of 703 trials